Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (1010)	2/18/2000 10:37:00 AM
From: arnie h	Read Replies (1) \| Respond to of 1386

Hi Cacaito: Thanks for your thoughtful and useful response. I'm sure management will be carefully looking at many details and weighing the various factors. Hopefully, they will come to the best decision for the shareholders and those in need of the therapy. Needless to say, the results from the 3rd cohort will be a most important detail. In the meantime, the upward movement in the stock price is good for the digestive system. Cheers, Arnie